Yixintang Pharmaceutical Group Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was CNY 3,995.4 million compared to CNY 3,428.55 million a year ago. Revenue was CNY 3,995.4 million compared to CNY 3,428.55 million a year ago. Net income was CNY 179.38 million compared to CNY 260.63 million a year ago. Basic earnings per share from continuing operations was CNY 0.3039 compared to CNY 0.4416 a year ago. Diluted earnings per share from continuing operations was CNY 0.3035 compared to CNY 0.44 a year ago.